The rest of the list expands to high expression of TRPV2 (Transient Receptor Potential Vanilloid 2) in cancerous skin cells, RXRB (Retinoid X Receptor Beta) in bone, and PPARG (Peroxisome Proliferator-Activated Receptor Gamma) in pancreatic cancer. This evidence concerns the gene TRPV2 and pancreatic neoplasm.